Log In
Print
BCIQ
Print
Print this Print this
 

TKM-PLK1 (PLK1424) (TKM-080301) (formerly PLK1 SNALP)

  Manage Alerts
Collapse Summary General Information
Company Tekmira Pharmaceuticals Corp.
DescriptionShort interfering RNA (siRNA) targeting polo-like kinase 1 (PLK1; STPK13) formulated in stable nucleic acid lipid particles (SNALP)
Molecular Target Polo-like kinase 1 (PLK1) (STPK13)
Mechanism of ActionGene silencing
Latest Stage of DevelopmentPhase I
IndicationCancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today